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E-mail addresses: cyril@good.ibl.fr, cyril.couturier@Leptin mediates its metabolic effects through several leptin receptor (LEP-R) isoforms. In humans,
long (LEPRb) and short (LEPRa,c,d) isoforms are generated by alternative splicing. Most of leptin’s
effects are believed to be mediated by the OB-Rb isoform. However, the role of short LEPR isoforms
and the possible existence of heteromers between different isoforms are poorly understood. Using
BRET1 and optimized co-immunoprecipitation, we observed LEPRa/b and LEPRb/c heteromers
located at the plasma membrane and stabilized by leptin. Given the widespread coexpression of
LEPRa and LEPRb, our results suggest that LEPRa/b heteromers may represent a major receptor spe-
cies in most tissues.
Structured summary:
MINT-7714817: LEPRb (uniprotkb:P48357-1) physically interacts (MI:0915) with LEPRb
(uniprotkb:P48357-1) by anti tag co-immunoprecipitation (MI:0007)
MINT-7714785: LEPRc (uniprotkb:P48357-2) physically interacts (MI:0915) with LEPRc
(uniprotkb:P48357-2) by bioluminescence resonance energy transfer (MI:0012)
MINT-7714951, MINT-7714744: LEPRa (uniprotkb:P48357-3) physically interacts (MI:0915) with LEPRa
(uniprotkb:P48357-3) by bioluminescence resonance energy transfer (MI:0012)
MINT-7714859: LEPRb (uniprotkb:P48357-1) physically interacts (MI:0915) with LEPRa
(uniprotkb:P48357-3) by anti tag co-immunoprecipitation (MI:0007)
MINT-7714885, MINT-7714672: LEPRb (uniprotkb:P48357-1) physically interacts (MI:0915) with LEPRb
(uniprotkb:P48357-1) by bioluminescence resonance energy transfer (MI:0012)
MINT-7714835: LEPRa (uniprotkb:P48357-3) physically interacts (MI:0915) with LEPRa (uni-
protkb:P48357-3) by anti tag co-immunoprecipitation (MI:0007)
MINT-7714914, MINT-7714723, MINT-7714759: LeprB (uniprotkb:P48357-1) physically interacts
(MI:0915) with LEPRa (uniprotkb:P48357-3) by bioluminescence resonance energy transfer (MI:0012)
MINT-7714703, MINT-7714936, MINT-7714772: LEPRb (uniprotkb:P48357-1) physically interacts
(MI:0915) with LEPRc (uniprotkb:P48357-2) by bioluminescence resonance energy transfer (MI:0012)
MINT-7714872: LEPRb (uniprotkb:P48357-1) physically interacts (MI:0915) with LEPRc (uni-
protkb:P48357-2) by anti tag co-immunoprecipitation (MI:0007)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction short (LEPRa, -Rc, -Rd) isoforms, which differ in the length of theirLeptin controls lipid homeostasis acting via its receptor (LEPR),
belonging to class I cytokine receptors [3]. In humans, alternative
splicing of the LEPR gene leads to expression of long (LEPRb) andchemical Societies. Published by E
energy transfer; Luc, lucifer-
fer
RS, Université Lille 2, Institut
45, 59021 Lille cedex, France.
univ-lille2.fr (C. Couturier).cytoplasmic tails [1]. LEPRa is expressed in most tissues while LEP-
Rb is mainly expressed in the hypothalamus where it plays a key
role in body weight regulation [2]. All transmembrane-containing
isoforms contain a conserved juxtamembrane box1 motif involved
in JAK2 recruitment. Upon leptin binding to LEPR, JAK2 is activated
and phosphorylates tyrosine residues only present in LEPRb, allow-
ing STAT3 recruitment and activation [3].
Using classical biochemical methods, in vitro studies reported
that LEPRa and LEPRb form homomers independently of leptinlsevier B.V. All rights reserved.
2214 J. Bacart et al. / FEBS Letters 584 (2010) 2213–2217stimulation [4–9]. However, heteromerization between different
isoforms remains controversial. So far, only one study reported lep-
tin-dependent heteromerization between LEPRa and LEPRb [6],
whereas most reports were unable to detect the formation of het-
eromers [5,8,10]. Nevertheless, this lack of evidence for LEPR het-
eromerization is surprising as (1) the extracellular domain shared
by all LEPR isoforms spontaneously homodimerizes in solution
[5,9]; and (2) LEPRb is systematically coexpressed with the ubiqui-
tously expressed LEPRa isoform [11,12]. Based on these observa-
tions, formation of LEPRa/b heteromers appears very likely in a
physiological context.
Using bioluminescence resonance energy transfer (BRET) and
co-immunoprecipitation assays, we show that LEPR isoforms form
heteromers likely by association of LEPRa and LEPRb dimers at the
cell surface. Furthermore these complexes are able to respond to
leptin stimulation suggesting a potential physiological role of the
short leptin receptor isoform on LEPRb physiology.
2. Materials and methods
2.1. DNA constructions
pcDNA3 LEPR(a and b)-Luc were previously described [7]. LE-
PR(a, b) and insulin Receptor (IR) YPet (Yellow ﬂuorescent protein
for energy transfer) fusion were generated by inserting YPet in
place of YFP (yellow ﬂuorescent protein) of previously described
YFP fusions proteins [7]. The 30-end of LEPRc cDNA was cloned
by RT-PCR from total HEK RNA (M-MLV Reverse Transcriptase, Pro-
mega; Fast taq, Roche) and inserted in pcDNA3-LEPRb-YPet to ob-
tain pcDNA3-LEPRc-YPet vector by replacing the 30-end of LEPRb.
YPet coding sequence was replaced by luciferase (Luc) to obtain
pcDNA3-LEPRc-Luc vector. Flag (DYKDDDK) and myc (EQKLI-
SEEDL) epitopes were respectively inserted between the signal
peptide and the N-terminal part of LEPR-Luc and LEPR-YPet con-
structs using PCR. The extracellular part of Erythropoietin receptor
cDNA was ampliﬁed by RT-PCR from total HEK mRNA and inserted
in frame of the TM and intracellular domain of pcDNA3-LEPRa-
YPet construct.
2.2. Cell culture and transfection
HEK293T cells were grown at 37 C and 5% CO2, in Dulbecco’s
modiﬁed eagle medium supplemented with glutamax, 10% fetal
bovine serum, penicillin (50 l/ml) and streptomycin (50 lg/ml)
(Invitrogen). Transfections were performed using Fugen-HD
(Roche Molecular Biochemicals) according to manufacturer
instructions.
2.3. BRET measurements
BRET was read on a Mithras LB940 luminometer (Berthold
Technologies, France) and calculated as previously described [7].
For some experiments, cells were preincubated 15 min with
100 nM leptin prior coelenterazin h addition. Total YPet ﬂuores-
cence reading was performed on a Fluostar Optima apparatus
(BMG Labtech, France).2.4. BRET donor saturation assay
HEK293T Cells were transfected using constant amount of
LEPR-Luc fusion proteins and increasing amount of each LEPR-YPet
fusion protein-expressing vectors., Cells were subjected to BRET
analysis 48 h post-transfection, and donor saturation curves were
generated and analyzed using Prism 5.0 (GraphPad) as previously
described [7,13].2.5. Crude, plasma and vesicular membrane preparation for BRET
measurement
Forty-eight hours post-transfection, membranes were prepared
from HEK293T cells transiently transfected with the different Luc
and YPet fusion proteins as previously described [13]. YPet/Luc ra-
tios were chosen in order to reach maximal BRET found in Fig. 1. In
some experiments, receptors were solubilized with or without lep-
tin (100 nM), for 2 h in NP 40 buffer previously successfully used to
detect LEPRb/LEPRa heteromers (2%NP40; 1X complete protease
inhibitor cocktail from Roche Diagnostics [6]) or in digitonin buffer
(75 mM Tris, 2 mM EDTA, 12 mM MgCl2, 1 X protease inhibitor
cocktail (Complete, Roche Diagnostics), and 0.5% digitonin (Sig-
ma–Aldrich). Lysates were centrifuged for 30 min at 48 000g,
and supernatant were used for BRET measurements.
Plasma and intracellular membrane were prepared by ultracen-
trifugation on a sucrose cushion (1.3 M) as previously described
[13] but we also collected the middle fraction from the upper inter-
face to the pellet. Upper (intracellular membrane) and pellets frac-
tions (plasma membranes) were immediately used for BRET
measurements.
2.6. Co-immunoprecipitation
Forty-eight hours post-transfection, HEK293T cells expressing
the indicated Flag-LEPR-Luc and Myc-LEPR-YPet fusion proteins
were lysed overnight at 4 C using 2% NP40 or 0.5% digitonin buf-
fer. For leptin stimulated conditions, 100 nM leptin was added
20 min prior cell lysis and during immunoprecipitation process.
Luciferase activity was measured and leveled amounts were sub-
jected to overnight immunoprecipitation using anti-myc antibody
and protein G sepharose. Pellets were washed three times with ly-
sis buffer and subjected to SDS–PAGE followed by Western-blot
analysis using anti-ﬂag M2 antibody (sigma).
2.7. Phospho-STAT3 detection
Forty-eight hours post-transfection, HEK293T cells expressing
constant amount of OB-Rb-YPet and increasing amount of OB-Ra-
Luc constructs were incubated or not for 30 min with 100 nM lep-
tin prior cells lysis (50 mM Tris–HCl, 100 mM NaCl, 2 mM EDTA,
1%Triton X-100, 0.1%SDS, 1 mM PMSF, 1X protease and phospha-
tase inhibitor complete cocktail, Roche Diagnostics). Then, Proteins
were subjected to Western-blot analysis and phosphorylated
STAT3 was detected using anti-phospho-STAT3 antibody (Tyr
705; cell signalling).
2.8. Statistical analysis
Statistical analyses were performed on at least three indepen-
dent experiments using two tailed Mann–Whitney test.
3. Results
3.1. Detection of LEPR heteromers in living cells by BRET
Protein interactions can be monitored by BRET in intact cells.
BRET1 is based on an energy transfer between the energy donor
Renilla luciferase (Luc) and the energy acceptor YFP that can be ob-
served if both proteins are less then 10 nm apart [14]. Using this
assay, we showed previously that LEPRa and LEPRb exist as pre-
formed homomers [7]. To verify the possible LEPR isoforms hetero-
merization, we used here an optimized BRET1 assay that replaced
the YFP energy acceptor by the YPet variant that shows improved
sensitivity [15]. Proper expression and cellular localization of the
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nor saturation assays were performed by coexpressing LEPRb-Luc
with LEPR(a, b or c)-YPet in HEK293T cells (Fig. 1B). Cells coex-
pressing LEPRb-Luc and LEPRb-YPet showed the expected high
and saturable energy transfer whereas no speciﬁc signals were
monitored when LEPRb-Luc was coexpressed with a negative insu-
lin receptor (IR)-YPet control or a chimeric construct composed of
extracellular domain of the erythropoietin receptor and intracellu-
lar domain of LEPRa-YPet. Interestingly, robust and speciﬁc BRET
signals were obtained in cells coexpressing LEPRb-Luc with LE-
PRa-YPet or LEPRc-YPet, indicative of LEPRa/b and LEPRb/c hetero-
mers formation (Fig. 1B). Similar results were obtained using
inverse energy transfer conﬁgurations (LEPRa-Luc/LEPRb-YPet
and LEPRc-Luc/LEPRb-YPet) (Fig. 1C and D). Donor saturation BRET
curves were saturable indicating the speciﬁcity of the interactions
as also observed for the corresponding LEPRa/LEPRa and LEPRc/
LEPRc homomers.
We then tested the effect of leptin stimulation on basal BRET
values observed for different LEPR isoform combinations
(Fig. 1E). In agreement with previous reports, BRET signals gener-
ated by LEPRb homomers were insensitive to leptin stimulation
whereas BRET signals from LEPRa homomers increased twofold
in the presence of leptin due to the conformational change induced
in preformed homomers [7,8]. Importantly, BRET signals of LEPRa/
b and LEPRb/c heteromers increased also signiﬁcantly in the pres-
ence of leptin. Similar values obtained for the two different LEPRa/
b BRET conﬁgurations demonstrate that this effect does not depend
on the BRET conﬁguration. Taken together, these results indicate
that LEPRa/b and LEPRb/c heteromers exist in intact HEK293T cells
and that these complexes are competent for leptin binding.
3.2. Stability of LEPR heteromers and their detection by co-
immunoprecipitation
Most previous reports failed to detect LEPR heteromers by co-
immunoprecipitation. As these experiments require extraction of
receptor complexes from membranes with detergents, dissociation
of LEPR heteromers cannot be ruled out. To study the stability of
solubilized LEPR heteromers at the basal and activated state, we
monitored BRET signals of leptin-activated or unstimulated com-
plexes before and after solubilization with 2% [vol/vol] NP40 or0.5% digitonin, a detergent known to preserve weak interactions
between membrane proteins [13,16] (Fig. 2A).
As previously reported [7], LEPRa homomers mostly dissociated
upon solubilization (drastic loss of BRET signal) with NP40 or dig-
itonin, whereas LEPRb homomers were partially resistant (only
40% reduction in BRET signals). Activation of LEPR prior to solubi-
lization did stabilize LEPRa complexes partially (only partial loss of
BRET signals), whereas no difference was observed for LEPRb com-
pared to the unstimulated state. Non-speciﬁc BRET levels were
evaluated by using the IR-YPet control [7]. BRET signals for LE-
PRa/b and LEPRb/c heteromers decreased upon solubilization with
NP40 or digitonin to levels similar to that observed for LEPRa hom-
omers in the presence of detergents, indicating the dissociation of
heteromers (Fig. 2A). Importantly, LEPR activation prior to solubi-
lization, reduced the decrease in LEPR heteromers BRET signals,
most likely due to partial stabilization of the complexes in the lep-
tin-activated state as observed for LEPRa homomers. Taken to-
gether, these data show that LEPR complexes are sensitive to
detergent treatment.
In order to further conﬁrm the interaction between short and
long isoforms of LEPR, we attempted to precipitate LEPR hetero-
mers by comparing leptin treated with untreated complexes that
have been solubilized with NP40 or digitonin, (Fig. 2B). LEPRb
homomers were easily detected irrespective of their activation
state, an observation that is completely consistent with BRET data
on solubilized receptors shown in Fig. 2A. The presence of LEPRa
homomers and LEPRa/LEPRb and LEPRb/LEPRc heteromers could
also be conﬁrmed under these conditions. Importantly, for theses
last ones, receptor activation prior solubilization signiﬁcantly in-
creased the amount of co-immunoprecipitated receptors further
demonstrating the increased stability of the complexes in activated
state. Taken together, co-immunoprecipitation data conﬁrm our
BRET data in intact cells showing the presence of LEPRa/b and LEP-
Rb/c heteromers. The sensitivity of these complexes to detergent
solubilization most likely explains difﬁculties to monitor LEPR het-
eromers in previous studies [5,6,10].
3.3. LEPR heteromerization at the cell surface
LEPRs are located at the plasma membrane and in intracellular
vesicles [17]. This conclusion has been drawn from cells expressing
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Fig. 2. LEPR heteromers stability and co-immunoprecipitation. (A) LEPR oligomers
stability upon solubilization. Crude membranes were extracted from HEK293T cells
expressing LEPR(a or b)-Luc donors and a saturating amount of the indicated YPet
fusion proteins. BRET signal were then monitored in these fractions prior
solubilization (h), and after solubilization with NP40 in presence ( ) or absence
of leptin (j), or digitonin in presence ( ) or absence of leptin ( ). Results from ﬁve
separate experiments are expressed in millibret unit (mBU) ±S.E.M. ***P < 0.001;
**P < 0.01; *P < 0.05. (B) Detection of LEPR heteromers by co-immunoprecipitation.
HEK293T cells were transiently transfected to express or not myc-tagged LEPR-
Ypet, and ﬂag-tagged LEPR-Luc indicated constructs at a ratio gaining maximal
BRET for each conditions. Cells were then lysed using NP40 or digitonin detergent
and anti-myc immunoprecipitation was performed in absence or presence of
100 nM leptin. Co-immunoprecipitated ﬂag-tagged LEPR fusion proteins were
revealed by Western-blot. Immunoblot representative of three separate
experiments.
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heteromers. In order to address this issue, we separated intracellu-
lar membranes from plasma membranes of HEK293T cells express-
ing LEPRb-Luc and LEPR(a, b, or c)-YPet fusion proteins at
saturating YPet/Luc ratios. Measuring the luciferase activity of LEP-
Rb-Luc in both compartments conﬁrmed the predominant (90%)
localization of LEPRb in intracellular membranes, which was not
modiﬁed by coexpression of LEPR(a, b, or c)-YPet proteins
(Fig. 3A). These YPet fusion proteins showed a similar repartition
between intracellular and plasma membranes as determined by
YPet ﬂuorescence measurements (data not shown).
Speciﬁc BRET signals (compared to the negative IR-YPet control)
were observed for LEPRb homomers in intracellular membranes
and plasma membranes as expected in the basal and leptin-acti-
vated state (Fig. 3B). Similarly, LEPRa homomers were detected
in intracellular and plasma membranes, with increased BRET sig-
nals in the presence of leptin, an observation that is consistent with
our data in intact cells (see Fig. 1E). Results for LEPRa/b and LEPRb/
c heteromers were different, as speciﬁc BRET signals were only ob-
served in the plasma membrane fraction. The lack of BRET signalsin intracellular membranes was not due to the absence of Luc or
YPet fusion proteins in this fraction, as luciferase activity
(Fig. 3A) and YPet ﬂuorescence (data not shown) were readily
detectable in this compartment.
As monitored for LEPRa homomers, BRET signal measured for
LEPR heteromers were increased in presence of leptin in these frac-
tions (Fig. 3B). These results suggests a functional role of these
complexes in leptin signalling. However, previous reports showed
the inability of excess LEPRa to inhibit LEPRb mediated STAT3 acti-
vation [6,18], our BRET constructions leading to LEPRa/b heteromer
detection also did not show inhibition in leptin-induced phosphor-
ylation of STAT3 (Fig. 3C). Taken together, our results indicate that
LEPR heteromers mainly localize at the cell surface, where they do
not seem to alter the JAK/STAT pathway induced by LEPRb.
4. Discussion
According to the current view of the LEPR structure and activa-
tion mechanism, receptors exist as preformed dimers, possibly sta-
bilized by S–S bridges between the extracellular cytokine receptor
homology (CRH)2 domain during the receptor biosynthesis [19].
Leptin is believed to induce conformational change and cell surface
clustering of preformed dimers into complexes comprising two
leptin molecules and four LEPR molecules (two dimers), thus trig-
gering downstream signalling of associated JAK2 proteins bring
into closer proximity. This model is mainly based on results ob-
tained with LEPRb homomers, due to the lack of convincing data
supporting the possibility of LEPR isoform heteromerization and
despite the known role of the CHR2 domain, common to all iso-
form, in LEPR oligomer formation. We present now new evidence
for the formation of such heteromeric complexes at the plasma
membrane that have to be integrated into this model.
Some reports including the present study showed that the coex-
pression of an excess of LEPRa has no effect on the activation of the
JAK/STAT pathway mediated by LEPRb [6,18]. These results are dif-
ﬁcult to reconcile with the formation of strict LEPR dimers as two
LEPRb molecules are necessary and sufﬁcient to promote STAT3
activation [20]. Hence, LEPRa should play a dominant negative role
on LEPRb signalling. In contrast, signalling of LEPRb in the presence
of LEPRa can be easily explained with the tetramer model com-
posed of a functional LEPRb dimer and LEPRa dimer. This model
is consistent with our data and the efﬁcient LEPR mediated JAK/
STAT signalling observed in hypothalamic nuclei [3,7] coexpressing
endogenous LEPRa and LEPRb isoforms [11,12]
Leptin-promoted BRET signals observed for LEPRa homomers
and LEPRa/b and LEPRb/c heteromers could be due to ligand-in-
duced clustering of receptors or conformational changes within
pre-existing complexes that bring the energy donor and acceptor
into closer proximity. Although the ﬁrst possibility can not be ex-
cluded at the current state, several arguments support the induc-
tion of conformational changes: (1) BRET experiments have been
performed at donor saturation by acceptor, a condition excluding
further protein recruitment; (2) previous energy transfer experi-
ments showed that the leptin-induced signal increase in LEPRa
homomers reﬂects a conformational change in pre-existing homo-
mers [7,8]. Moreover, our co-immunoprecipitation studies do not
provide any evidence for leptin-induced LEPRb clustering. Assum-
ing a common activation mechanism for all LEPR isoforms, the lep-
tin-induced increase of precipitated LEPRa/b and LEPRb/c
heterodimers most likely represents leptin-promoted stabilization
of preformed complexes rather than leptin-promoted clustering.
Formation of leptin-responsive LEPRa/LEPRb complexes at the
cell surface suggests a potential physiological role of these hetero-
mers. The lack of a negative dominant effect of LEPRa on LEPRb-
promoted STAT3 activation indicates that this pathway is not mod-
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possible effect on STAT3 activation kinetics. Indeed, LEPRa and LEP-
Rb have different internalization mechanisms: ubiquitin-depen-
dent or -independent, respectively [22]. One isoform could
change the half-life of the other at the cell surface and thus, mod-
ulate activation kinetics. Furthermore, currently unknown hetero-
mer-speciﬁc signalling pathways could be activated and may
involve JAK2 activation as both LEPRa and LEPRb dimers contain
speciﬁc JAK2 binding sites [21].
The present study provides evidence for LEPR heteromerization
and raises the question of its potential biological effects, encourag-
ing further studies on the biological implications of the short LEPR
isoforms in leptin physiology.
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